PUTRAJAYA: The National Pharmaceutical Regulatory Agency (NPRA) has approved an application from Solution Biologics Sdn Bhd, regarding the extension of the shelf life of the Covid-19 vaccine, Convidecia Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Solution for Injection.
NPRA senior director , Norhaliza A Halim, said that the new approved shelf life was from 15 months to 18 months when stored at a temperature of 2°C to 8°C.
She said that the extension of the shelf life involved the MAL21066050AZ vaccine, manufactured at CanSino Biologics Inc, China, and MAL22126013ASZ manufactured at Solution Biologics Sdn Bhd, Malaysia. "The extension of the product's shelf life has been given based on the latest stability data submitted by the manufacturer.
"The approval of this shelf life extension is retrospective, meaning that this approval also applies to all stocks, including all stocks that have been received before this shelf life extension was approved," she said in a statement on Saturday . Norhaliza said that the Health Ministry was always committed to ensuring that all pharmaceutical products, including the Covid-19 vaccines supplied in Malaysia, have been assessed in terms of quality, safety and effectiveness by the NPRA. - Bernama
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: NPRA approves shelf life extension for Covid-19 Comirnaty vaccinePUTRAJAYA: The National Pharmaceutical Regulatory Agency (NPRA) has approved a variation application from Pfizer (Malaysia) Sdn Bhd in relation to updating the shelf life of Covid-19 Comirnaty Concentrate for Dispersion for Injection vaccine.
Read more »
Jangka hayat produk vaksin Covid-19 Convidecia dilanjutkan, kata NPRA | The Malaysian InsightTempoh jangka hayat baharu yang diluluskan adalah daripada 15 bulan kepada 18 bulan apabila disimpan pada suhu 2°C sehingga 8°C.
Read more »
Jangka hayat vaksin Covid Comirnaty dilanjutkan, kata NPRA | The Malaysian InsightTempoh yang diluluskan adalah daripada 15 bulan kepada 18 bulan, kata pengarah farmasi.
Read more »
Harga ubat tradisional Cina dijangka meningkat selepas Tahun Baharu Cina | The Malaysian InsightRamai yang menjadikan ubatan herba Cina sebagai tambahan kepada ubat dari barat untuk merawat Covid-19.
Read more »
China says critical Covid cases have peaked as holiday travel surgesMillions travel across the country for long-awaited reunions with families.
Read more »